20-Panel Drug Test
The 20-Panel Drug Test adds buprenorphine, kratom, synthetic cannabinoids, and synthetic cathinones (bath salts) to the list of substances being screened. This test covers marijuana (THC), cocaine, opiates, amphetamines, phencyclidine (PCP), benzodiazepines, barbiturates, methadone, propoxyphene, methaqualone, MDMA, oxycodone, tramadol, fentanyl, meperidine, ketamine, buprenorphine, kratom, synthetic cannabinoids, and synthetic cathinones.
Comprehensive Screening for High-Risk Environments
The 20-Panel Drug Test covers 20 different substances, including commonly abused drugs and hard-to-detect substances like buprenorphine and synthetic cathinones, making it ideal for high-risk settings.
This test provides highly accurate detection for both prescription drugs and illicit substances, ensuring that individuals are not using drugs that could impair their performance.
Addiction treatment centers use the 20-Panel Test for its comprehensive drug screening capabilities, allowing them to monitor the substance use of patients in recovery.
For workplaces with strict safety standards, the 20-Panel Test ensures that employees are not under the influence of substances that could cause harm or reduce productivity.
The 20-Panel Test is designed for use in environments where thorough drug testing is necessary, such as law enforcement, legal investigations, or high-security workplaces.